File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Progress in clinical application of transcarotid artery revascularization

TitleProgress in clinical application of transcarotid artery revascularization
经颈动脉血运重建术的临床应用进展
Authors
Issue Date31-Oct-2024
PublisherChinese Medical Association on behalf of Chinese Association for Science and Technology
Citation
Chinese Journal of Vascular Surgery, 2024, v. 9, n. 5, p. 341-345 How to Cite?
Abstract

Carotid artery atherosclerotic stenosis is the main cause of cerebral ischemia syndrome. Carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TFCAS) are the mainstream surgical methods for the treatment of carotid artery stenosis. CEA has been recommended as the first-line surgical treatment in symptomatic patients with more than 50% carotid stenosis and asymptomatic cases with more than 70% stenosis. However, there is a high risk of myocardial infarction after CEA and stroke after TFCAS. Gradually, transcarotid artery revascularization, without compromising hemodynamics, has gained popularity in the treatment of carotid stenosis due to its lower rates of perioperative microembolization, brain injury detected by MRI, and complications including neurological events, myocardial infarction, and mortality.


颈动脉粥样硬化性颈动脉狭窄是导致脑缺血综合征的主要原因,颈动脉内膜剥脱术(CEA)与经股动脉颈动脉支架植入术(TFCAS)是目前治疗颈动脉狭窄的主流手术方式。对于有症状的颈动脉狭窄且狭窄程度大于50%和无症状的颈动脉狭窄且狭窄程度大于70%,CEA 已被推荐为一线手术治疗方案。CEA术后心肌梗死及TFCAS术后脑卒中发生的风险较高,经颈动脉血运重建术在不破坏血流动力学条件下,因其围术期微栓塞,磁共振成像可检测到的脑损伤以及神经系统事件、心肌梗死和死亡等相关并发症发生率较低,逐渐被推广。
Persistent Identifierhttp://hdl.handle.net/10722/353798
ISSN

 

DC FieldValueLanguage
dc.contributor.authorPeng, Tao-
dc.contributor.authorLiu, Jingsi-
dc.contributor.authorLi, Hailei-
dc.date.accessioned2025-01-24T00:35:55Z-
dc.date.available2025-01-24T00:35:55Z-
dc.date.issued2024-10-31-
dc.identifier.citationChinese Journal of Vascular Surgery, 2024, v. 9, n. 5, p. 341-345-
dc.identifier.issn2096-1863-
dc.identifier.urihttp://hdl.handle.net/10722/353798-
dc.description.abstract<p>Carotid artery atherosclerotic stenosis is the main cause of cerebral ischemia syndrome. Carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TFCAS) are the mainstream surgical methods for the treatment of carotid artery stenosis. CEA has been recommended as the first-line surgical treatment in symptomatic patients with more than 50% carotid stenosis and asymptomatic cases with more than 70% stenosis. However, there is a high risk of myocardial infarction after CEA and stroke after TFCAS. Gradually, transcarotid artery revascularization, without compromising hemodynamics, has gained popularity in the treatment of carotid stenosis due to its lower rates of perioperative microembolization, brain injury detected by MRI, and complications including neurological events, myocardial infarction, and mortality.<br></p>-
dc.description.abstract颈动脉粥样硬化性颈动脉狭窄是导致脑缺血综合征的主要原因,颈动脉内膜剥脱术(CEA)与经股动脉颈动脉支架植入术(TFCAS)是目前治疗颈动脉狭窄的主流手术方式。对于有症状的颈动脉狭窄且狭窄程度大于50%和无症状的颈动脉狭窄且狭窄程度大于70%,CEA 已被推荐为一线手术治疗方案。CEA术后心肌梗死及TFCAS术后脑卒中发生的风险较高,经颈动脉血运重建术在不破坏血流动力学条件下,因其围术期微栓塞,磁共振成像可检测到的脑损伤以及神经系统事件、心肌梗死和死亡等相关并发症发生率较低,逐渐被推广。-
dc.languagechi-
dc.publisherChinese Medical Association on behalf of Chinese Association for Science and Technology-
dc.relation.ispartofChinese Journal of Vascular Surgery-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleProgress in clinical application of transcarotid artery revascularization-
dc.title经颈动脉血运重建术的临床应用进展-
dc.typeArticle-
dc.identifier.doi10.3760/cma.j.cn101411-20231220-00056-
dc.identifier.volume9-
dc.identifier.issue5-
dc.identifier.spage341-
dc.identifier.epage345-
dc.identifier.issnl2096-1863-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats